Sunnyvale, California, – Molecular Devices®, market leader in the electrophysiology and biophysical research markets for over 30 years, announced today it has made an agreement with Fluxion Biosciences to become global distributor for the IonFlux™ portfolio of instrumentation and consumables. Molecular Devices will also provide support for all IonFlux Systems users through its recently expanded […]
Grenoble, France,– CYTOO, a French biotechnology company providing research and development tools based on cell architecture, welcomes Marc Le Bozec as Chief Executive Officer. For more than 15 years, Marc Le Bozec has been a major stakeholder in industrial and academic biotechnologies in France. For several years, he worked as a consultant in organization (Bossard […]
BILLERICA, Mass — EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today accepted the Chairman’s Award from Governor Deval Patrick at the Associated Industries of Massachusetts (AIM) Annual Meeting held in Waltham, MA. This award recognizes a Massachusetts firm, institution or public agency of any size that has demonstrated excellence in […]
HOLLISTON, Mass., — Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its Board of Directors has appointed David Green, the Company’s President and member of the Board since 1996, as interim Chief Executive Officer following the […]
ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX) today announced that Franklin M. Berger, CFA, 63, has been appointed to its Board of Directors. “We are pleased to welcome a recognized biotechnology industry expert of Franklin’s caliber to BioTime’s Board,” said Alfred D. Kingsley, Chairman of the Board of BioTime. “Franklin adds to our Board a […]
Golden, Colorado —— Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced expansion of its distribution agreement with Neuromics to include targeted sales to select markets in drug discovery & regenerative medicine. Early stages of drug development rely on in-vitro assays to identify effective new drugs and these assays are based on cellular systems. Vitro […]
Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) announced today the issuance of a new patent covering nucleic acids encoding Transcription Activator-Like Effector Nuclease fusion proteins (TALENS) and the formal launch of an associated sublicensing program. The technology has broad utility in the pharmaceutical industry, synthetic biology, and plant sciences for creating genetically modified cell […]
ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the first quarter ended March 31, 2013 and highlighted recent corporate accomplishments. First Quarter and Recent Corporate Accomplishments Entered into an Asset Contribution Agreement with Geron Corporation (“Geron”) and […]
Sunnyvale, California – Molecular Devices®, market leader in the electrophysiology and biophysical research markets for over 30 years, announced today the launch of its next generation Axon™ Digidata® 1550 Low-Noise Data Acquisition System. Considered the industry standard in neuroscience research labs, the new Digidata Platform enables the parallel patching of up to eight cells simultaneously […]
Billerica, MA and London, UK — EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, and Plasticell of London, UK, today announced the availability of OsteoMAX-XF™, the first fully defined, xeno-free human mesenchymal stem cell differentiation medium for the differentiation of mesenchymal stem cells into osteocytes. Mineralization can be detected in less […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
